Yunfeng Pan
Overview
Explore the profile of Yunfeng Pan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
1933
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu J, Zhang Y, Xu X, Dong X, Pan Y, Sun X, et al.
Pharmacol Res
. 2024 Dec;
211():107562.
PMID: 39732351
Diabetic retinopathy (DR) is a blinding complication of microangiopathy. First-line therapeutic drugs are all focused on late-stage DR and have several side effects, which could not meet clinical needs. The...
2.
Pan Y, Sun X, Tian Y, Yu M, Luo Y, Sun X
Biomed Pharmacother
. 2024 Oct;
180:117588.
PMID: 39427550
Introduction: L-NRB is a compound formed as a ring cleavage product of butylphthalide and borneol in a molar ratio 1:2. This study aimed to explore the therapeutic effect of L-NRB...
3.
Shan X, Peng C, Zou H, Pan Y, Wu M, Xie Q, et al.
Nutrients
. 2024 Jul;
16(14).
PMID: 39064743
(1) Introduction: Previous studies have found that diet can change gut microbiota, thereby affecting metabolic health. However, research on gestational diabetes mellitus (GDM) is still limited. Our study aimed to...
4.
Shi X, Liao T, Chen Y, Chen J, Liu Y, Zhao J, et al.
Arch Pharm Res
. 2024 Jul;
47(7):632-644.
PMID: 38977652
Systemic lupus erythematosus (SLE) is a common autoimmune disease, and its pathogenesis mainly involves the aberrant activation of B cells through follicular helper T (Tfh) cells to produce pathogenic antibodies,...
5.
Pan Y, Xue Q, Yang Y, Shi T, Wang H, Song X, et al.
Cell Rep Med
. 2024 Jun;
5(6):101590.
PMID: 38843844
Despite the important breakthroughs of immune checkpoint inhibitors in recent years, the objective response rates remain limited. Here, we synthesize programmed cell death protein-1 (PD-1) antibody-iRGD cyclic peptide conjugate (αPD-1-(iRGD))...
6.
Xie Q, Yong C, Xiang C, Xi Y, Huo J, Liang J, et al.
Children (Basel)
. 2024 May;
11(5).
PMID: 38790525
(1) Background: With autistic children's high pervasiveness of eating problems and inappropriate feeding behaviors by their caregivers, this study wanted to inspect the connection between caregivers' pressure to eat and...
7.
Chen J, Shi X, Deng Y, Dang J, Liu Y, Zhao J, et al.
JCI Insight
. 2024 Apr;
9(10).
PMID: 38652539
Mesenchymal stem cells (MSCs) have demonstrated potent immunomodulatory properties that have shown promise in the treatment of autoimmune diseases, including rheumatoid arthritis (RA). However, the inherent heterogeneity of MSCs triggered...
8.
Sun X, Pan Y, Luo Y, Guo H, Zhang Z, Wang D, et al.
J Ethnopharmacol
. 2023 Dec;
322:117672.
PMID: 38159826
Aim Of The Study: Naoxinqing (NXQ) tablets are derived from persimmon leaves and are widely used in China for promoting blood circulation and removing blood stasis in China. We aimed...
9.
Liu Y, Luo X, Chen Y, Dang J, Zeng D, Guo X, et al.
Redox Biol
. 2023 Dec;
69:103008.
PMID: 38142586
Focal iron overload is frequently observed in patients with rheumatoid arthritis (RA), yet its functional significance remains elusive. Herein, we report that iron deposition in lesion aggravates arthritis by inducing...
10.
Chen Y, Liang R, Shi X, Shen R, Liu L, Liu Y, et al.
Biomed Pharmacother
. 2023 Nov;
169:115886.
PMID: 37992572
IL-2 inducible T cell kinase (ITK) is critical in T helper subset differentiation and its inhibition has been suggested for the treatment of T cell-mediated inflammatory diseases. T follicular helper...